Termination of licensing agreement for bioprinting of scaffolds for lung transplants

Rehovot, israel, feb. 25, 2021 /prnewswire/ -- collplant biotechnologies (nasdaq: clgn) a regenerative and aesthetics medicine company, today announced that on february 24, 2021 it received a notice from lung biotechnology, a united therapeutics subsidiary, informing the company of the...

CLGN Ratings Summary

CLGN Quant Ranking